Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options
Russell Lewis, Jan Philipp Bewersdorf, Amer M Zeidan Department of Medicine, Section of Hematology, Yale University, New Haven, CT, USACorrespondence: Amer M ZeidanDepartment of Medicine, Section of Hematology, Smilow Cancer Center at Yale New Haven Hospital, 333 Cedar Street, PO Box 208028, New Hav...
Main Authors: | Lewis R, Bewersdorf JP, Zeidan AM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-01-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-management-of-anemia-in-patients-with-myelodysplastic-syndrom-peer-reviewed-article-CMAR |
Similar Items
-
Therapeutic Options in Myelodysplastic Syndromes: Established and Emerging Therapies
by: Nina Kim, et al.
Published: (2018-08-01) -
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study
by: Konstantinos Liapis, et al.
Published: (2020-07-01) -
Therapeutic Options in Myelodysplastic Syndromes Following Hypomethylating Agent Failure
by: Abigail Belasen, et al.
Published: (2020-07-01) -
Oxidative Stress Parameters Can Predict the Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndrome Patients
by: Ana Cristina Gonçalves, et al.
Published: (2021-06-01) -
Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States
by: Eric D. Weinhandl, et al.
Published: (2023-12-01)